Business Standard

Covid-19: Vaccine firms give Moderna a shrug, say no rush on tie-ups

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have

covid-19, vaccine, coronavirus
Premium

Sohini Das Mumbai
Indian vaccine makers are in no hurry to tie up with US biotech major Moderna to bring its mRNA vaccine candidate to India.

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have. 
 
Pune’s Serum Institute, which has tied up with AstraZeneca-University of Oxford for the AZD-1222 candidate, said that it already had a better m-RNA candidate.
 
Two other vaccine players said they would rather watch keenly how the Moderna vaccine develops after it goes to phase 3, and are in no rush to tie

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in